Abbott在印度引进了无铅起搏器,提供最低程度的侵入性植入和增强病人护理。 Abbott introduces leadless pacemaker in India, offering minimally invasive implantation and enhanced patient care.

Abbott在印度启动了由CDSCO和美国林业发展局批准的AVEIR VR无铅心脏起搏器。 Abbott has launched the AVEIR VR leadless pacemaker in India, approved by CDSCO and the US FDA. 这种装置通过最低限度的侵入性程序直接植入心脏,消除胸切口和电线。 This device is implanted directly into the heart via a minimally invasive procedure, eliminating chest incisions and wires. 与传统的心脏起搏器相比,它更容易植入、恢复和增加电池寿命,减少并发症,加强病人的护理。 It offers easier implantation, retrievability, and increased battery life compared to traditional pacemakers, reducing complications and enhancing patient care.